Viewing Study NCT02937818


Ignite Creation Date: 2025-12-25 @ 4:49 AM
Ignite Modification Date: 2026-03-01 @ 3:55 PM
Study NCT ID: NCT02937818
Status: COMPLETED
Last Update Posted: 2024-06-07
First Post: 2016-10-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Platinum Refractory Extensive-Stage Carcinoma, Small Cell Lung View
None Platinum Refractory Extensive-Stage Oat Cell Carcinoma of Lung View
None Platinum Refractory Extensive-Stage Oat Cell Lung Cancer View
None Platinum Refractory Extensive-Stage Small Cell Cancer Of The Lung View
None Platinum Refractory Extensive-Stage Small Cell Lung Cancer View